Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, PET, FVT

Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth Conference


SAN FRANCISCO, Sept. 9, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will participate in the H.C. Wainwright Global Investment Conference on September 14-15, the Cantor Global Healthcare Conference on September 16, and the Lake Street Best Ideas Growth Conference on September 17.  

Dr. Richard Chin, Chief Executive Officer, will present and be available for one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, study results from key therapeutic programs in development, and upcoming milestones.

Conference Details:

H.C. Wainwright Global Investment Conference

Date: September 14-15, 2020

Presentation time: 3:30?3:50p.m. ET, September 15, 2020

Webcast URL: Click here

Cantor Global Healthcare Conference

Date: September 16, 2020

Presentation time: 2:40?3:10p.m. ET

Webcast URL: Click here

Lake Street Best Ideas Growth Conference

Date: September 17, 2020

An archived version of the above webcasts will be available for 30 days on the KindredBio website.

About Kindred Biosciences 

Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.

For more information, visit: www.kindredbio.com

Contact

Katja Buhrer 
[email protected] 
(917) 969-3438

 

SOURCE Kindred Biosciences, Inc.


These press releases may also interest you

at 13:56
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patientsGastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare cancer that...

at 13:40
From 'the big one' to big relief for Adena Health heart attack patient
Jesse Patterson has always been more of a self-treatment type of guy when it comes to dealing with his health. So, when the normally active 73-year-old New Holland resident started getting short of breath and felt his lungs burning when he walked any...

at 13:12
Radians quarterly grassroots Tickets for Charity program empowers Midsouth nonprofits JIFF and The ARC Northwest Mississippi
Empowered by employee donations and matched by management contributions, Radians® quarterly Tickets for Charity (TFC) program champions local Memphis and Midsouth charities, offering crucial support for sustaining daily operations and expanding their...

at 13:07
Multi-talented Emmy® Award-Winning Host & Actress Tamera Mowry-Housley Set to Receive Trailblazer Award at A Pink Pump Affair
Multi-award-winning Civil Rights Attorney and Child Advocate, Areva Martin, in collaboration with the Special Needs Network (SNN), has revealed the distinguished honorees for the 16th Annual A Pink Pump Affair. This noteworthy charity event is...

at 13:05
Convergent Dental's "Solea User Group Meeting" Rebranded to "Solea Summit"
Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, proudly announces the rebranding of its annual customer event from the "Solea User Group Meeting" to the "Solea Summit." This update reflects the evolution of the event into the...

at 13:00
Laniado Hospital Kicks Off Major Campaign For Building New Rocket-Proof Emergency Building In Netanya
The Laniado Hospital in Netanya, Israel, is embarking on a crucial initiative to construct the country's first fully sheltered emergency care building. With the support of the Laniado Development Fund, this endeavor aims to enhance public healthcare...

More news about Health...


News published on and distributed by: